Leap Therapeutics's total assets for Q2 2024 were $81.43M, an increase of 40.48% from the previous quarter. LPTX total liabilities were $15.64M for the fiscal quarter, a 47.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.